Early response to therapy and outcome in childhood acute lymphoblastic leukemia
Paul S. Gaynon(University of Wisconsin American Family Children's Hospital), Fatih M. Uckun(University of Southern California), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Anish Desai, Michael E. Trigg(University of Iowa), Harland N. Sather(University of Southern California), James B. Nachman(University of Chicago), Beverly J. Lange(Philadelphia University), Bruce Bostrom(Minnesota West Community & Technical College), David G. Tubergen(University of Michigan), Gregory H. Reaman(National Cancer Institute)
Cited by 230
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
|Journal of Clinical Oncology|2001|825
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
|Cancer Cell|2012|722
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy
|Journal of neurosurgery|1994|508